Clinical Trial Update: A Study in Adult Males With X-linked Congenital Nephrogenic Diabetes Insipidus to Test the Effects of NDI-5001 Given for Multiple Days and to Test How NDI-5001 is Tolerated and Taken up in the Body [Phase 1]

View source ↗

Summary

Phase 1 clinical trial in adult males with X-linked congenital nephrogenic diabetes insipidus to assess the effects and tolerability of NDI-5001 over multiple d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• X-linked Congenital Nephrogenic Diabetes Insipidus

Drugs mentioned

• NDI-5001

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: X-linked Congenital Nephrogenic Diabetes Insipidus | Phase 1 | Status: NOT_YET_RECRUITING